Health, Fitness & Food

In this article ME Follow your favorite stocksCREATE FREE ACCOUNT Anne Wojcicki, co-founder and chief executive officer of 23andme Inc., during the South by Southwest (SXSW) festival in Austin, Texas, US, on Friday, March 10, 2023.  Jordan Vonderhaar | Bloomberg | Getty Images All seven independent directors of 23andMe resigned from the company’s board Tuesday,

Nurphoto | Getty Images The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to enter into the “frenzy” of weight loss drugs, preferring instead to focus on areas where it can build a “unique position.” Speaking to CNBC, Vas Narasimhan said that the company was researching treatments that deal with

In this article RHHBF Follow your favorite stocksCREATE FREE ACCOUNT Headquarters of Roche, multinational pharmaceutical industry on December 27, 2021 in Madrid, Spain.  Cristina Arias | Cover | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to

Drugmakers are betting that delivering radiation directly to tumors will become the next big cancer breakthrough.  Bristol Myers Squibb, AstraZeneca, Eli Lilly and other pharmaceutical companies have spent some $10 billion on deals to acquire or work with radiopharmaceuticals makers. They’ve snapped up smaller upstarts to get their hands on technology that, while in its

In this article AAPL Follow your favorite stocksCREATE FREE ACCOUNT Tim Cook, chief executive officer of Apple Inc., during an event at Apple Park campus in Cupertino, California, US, on Monday, Sept. 9, 2024. Apple Inc. unveiled a new version of its smartwatch with a bigger screen and the ability to detect sleep apnea, part

Experts call it “economy class syndrome” — but it can happen to anyone in any class of an airplane. Deep vein thrombosis, or DVT as it’s known, occurs when blood clots in one or more veins. It can happen at any time, but people who travel on long-haul flights are at a higher risk because

In this article PFE Follow your favorite stocksCREATE FREE ACCOUNT Kena Betancur | Corbis News | Getty Images Pfizer‘s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial, the drugmaker said Saturday.  Patients with the condition, called cancer cachexia, who

In this article MRNA Follow your favorite stocksCREATE FREE ACCOUNT Moderna headquarters, exterior view, Cambridge, Massachusetts, USA.  Plexi Images | GHI | UCG | Universal Images Group | Getty Images Moderna on Thursday said it plans to cut around $1.1 billion in expenses by 2027 and win approvals for several new products as it charts a

Zoom In IconArrows pointing outwards Noom GLP-1 RX Courtesy of Noom Digital health company Noom on Thursday announced it will offer a compounded GLP-1 drug as part of a new weight loss product that starts at $149.  The treatment will feature compounded semaglutide, the same active ingredient in Novo Nordisk‘s blockbuster obesity and diabetes drugs

In this article AAPL Follow your favorite stocksCREATE FREE ACCOUNT Apple AirPods Pro Apple Soon, people with AirPods in their ears might not be drowning you out — they might be wearing them to hear you better. Apple announced on Monday that its AirPods Pro 2 headphones will become an FDA-cleared hearing aid in the

In this article GILD Follow your favorite stocksCREATE FREE ACCOUNT A pharmacist holds a vial of lenacapavir, the new HIV prevention injectable drug. Nardus Engelbrecht | AP Gilead‘s twice-yearly shot reduced HIV infections by 96% in a second large study, the company said Thursday. The positive phase-three trial data on lenacapavir sets the stage for

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Thursday said it will invest $1.8 billion to boost manufacturing for its newly approved Alzheimer’s drug and

Safi employees at work. Courtesy of Safi Biotherapeutics Last month, the American Red Cross declared an emergency blood shortage after its national supply fell by more than 25% in July. One startup’s solution: Lab-grown blood. Shortages can be dire for patients since doctors have to make tough decisions about who needs blood transfusions the most.

In this article AAPL Follow your favorite stocksCREATE FREE ACCOUNT Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care

An illustrative image of a person holding a medical syringe and a Covid-19 vaccine vial in front of the the AstraZeneca logo displayed on a screen. On Wednesday, January 12, 2021, in Edmonton, Alberta, Canada. (Photo by Artur Widak/NurPhoto via Getty Images) Nurphoto | Nurphoto | Getty Images AstraZeneca shares fell more than 5% Tuesday

In this article ESALY 4523.T-JP BIIB Follow your favorite stocksCREATE FREE ACCOUNT Hannah Yoon | The Washington Post | Getty Images Leqembi, an Alzheimer’s drug from Biogen and Eisai, isn’t a cure for the mind-damaging disease.  But the treatment promises to give patients such as Missie Meeks more time to live their daily lives normally

In this article ABT Follow your favorite stocksCREATE FREE ACCOUNT A man wearing Abbott’s Lingo biosensor. Courtesy of Abbott Abbott Laboratories announced Thursday its over-the-counter continuous glucose monitor Lingo is available in the U.S. starting at $49.  Lingo is part of an emerging class of consumer-friendly biosensors that people can use to learn how their

In this article LLY Follow your favorite stocksCREATE FREE ACCOUNT A sign with the company logo outside the headquarters of Eli Lilly and Company in Indianapolis, Indiana, March 17, 2024. Scott Olson | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. More weakness: There’s been a couple attempts at a rally Wednesday, but stocks are still mostly lower in the second session of September after a rough

Shortly after the opening bell, we’ll be selling 10 shares of Eli Lilly at roughly $958 each. Following Monday’s trade, Jim Cramer’s Charitable Trust will own 100 shares of LLY, decreasing its weighting to 2.85% from about 3.13%. Now that we are no longer restricted, we are selling some Eli Lilly shares. We downgraded Lilly